David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.58% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 8.87% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
PUT
Ovintiv
OVV
$17.8B
| $2.72M | ﹤0.01% |
67,200
+10,600
| +19% | +$441K |
|
2352
CALL
Darling Ingredients
DAR
$9.61B
| $2.72M | ﹤0.01% |
80,700
+10,800
| +15% | +$408K |
|
2353
TriMas Corp
TRS
$1.41B
| $2.72M | ﹤0.01% |
110,546
-29,809
| -21% | -$781K |
|
2354
Autoliv
ALV
$8.94B
| $2.72M | ﹤0.01% |
+28,979
| New | +$2.79M |
|
2355
CALL
Tapestry
TPR
$25.1B
| $2.72M | ﹤0.01% |
41,600
+35,000
| +530% | +$1.91M |
|
2356
Equifax
EFX
$22.6B
| $2.72M | ﹤0.01% |
10,664
+7,563
| +244% | +$2.03M |
|
2357
Morgan Stanley Direct Lending Fund
MSDL
$1.29B
| $2.71M | ﹤0.01% |
+131,395
| New | +$2.69M |
|
2358
CALL
Allegiant Air
ALGT
$2.24B
| $2.71M | ﹤0.01% |
28,800
-13,100
| -31% | -$955K |
|
2359
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.86B
| $2.71M | ﹤0.01% |
35,149
+30,597
| +672% | +$2.44M |
|
2360
Rhythm Pharmaceuticals
RYTM
$7.61B
| $2.7M | ﹤0.01% |
48,198
+43,904
| +1,022% | +$2.43M |
|
2361
Resources Connection
RGP
$146M
| $2.69M | ﹤0.01% |
315,665
+105,984
| +51% | +$893K |
|
2362
PUT
Carlyle Group
CG
$17.6B
| $2.69M | ﹤0.01% |
+53,300
| New | +$2.7M |
|
2363
FNB Corp
FNB
$6.51B
| $2.69M | ﹤0.01% |
181,958
-228,713
| -56% | -$3.51M |
|
2364
PUT
Mondelez International
MDLZ
$79.7B
| $2.69M | ﹤0.01% |
+45,000
| New | +$2.98M |
|
2365
PUT
Polaris
PII
$3.63B
| $2.68M | ﹤0.01% |
46,500
+25,800
| +125% | +$1.8M |
|
2366
Cirrus Logic
CRUS
$5.5B
| $2.67M | ﹤0.01% |
26,819
-43,102
| -62% | -$4.74M |
|
2367
Avis
CAR
$5.09B
| $2.67M | ﹤0.01% |
33,122
-10,499
| -24% | -$957K |
|
2368
Pulmonx
LUNG
$110M
| $2.67M | ﹤0.01% |
392,836
+32,049
| +9% | +$211K |
|
2369
PUT
Bumble
BMBL
$360M
| $2.67M | ﹤0.01% |
327,500
| – | – |
|
2370
PUT
Axsome Therapeutics
AXSM
$10.7B
| $2.67M | ﹤0.01% |
31,500
| – | – |
|
2371
CALL
Tanger
SKT
$4.33B
| $2.66M | ﹤0.01% |
78,000
| – | – |
|
2372
Rackspace Technology
RXT
$892M
| $2.66M | ﹤0.01% |
1,203,806
+29,047
| +2% | +$73.3K |
|
2373
Cogent Biosciences
COGT
$6.39B
| $2.65M | ﹤0.01% |
339,988
-117,240
| -26% | -$1.17M |
|
|
GAP
2374
CALL
The Gap Inc
GAP
$7.52B
| $2.65M | ﹤0.01% |
112,200
-22,700
| -17% | -$517K |
|
2375
PUT
Omega Healthcare
OHI
$14B
| $2.65M | ﹤0.01% |
+70,000
| New | +$2.8M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $7.08B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.